Logo image of 1FRE.MI

FRESENIUS SE & CO KGAA (1FRE.MI) Stock Price, Forecast & Analysis

Europe - Euronext Milan - BIT:1FRE - DE0005785604 - Common Stock

46.46 EUR
+0.28 (+0.61%)
Last: 12/1/2025, 7:00:00 PM

1FRE.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap26.17B
Revenue(TTM)22.23B
Net Income(TTM)1.13B
Shares563.24M
Float411.16M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend0
Dividend Yield2.12%
EPS(TTM)3.27
PE14.21
Fwd PE12.52
Earnings (Next)11-05 2025-11-05
IPO1986-12-18
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


1FRE.MI short term performance overview.The bars show the price performance of 1FRE.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

1FRE.MI long term performance overview.The bars show the price performance of 1FRE.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1FRE.MI is 46.46 EUR. In the past month the price increased by 72.27%.

FRESENIUS SE & CO KGAA / 1FRE Daily stock chart

1FRE.MI Competitors/Peers

The largest stocks on the EU markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
FRE.DE FRESENIUS SE & CO KGAA 13.9 26.70B
FME.DE FRESENIUS MEDICAL CARE AG 10.49 23.14B
V3V.DE FAMICORD AG 38.93 96.14M

About 1FRE.MI

Company Profile

1FRE logo image Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 176,207 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.

Company Info

FRESENIUS SE & CO KGAA

Else-Kroener-Str. 1

BAD HOMBURG HESSEN DE

Employees: 176207

1FRE Company Website

1FRE Investor Relations

Phone: 4961726080

FRESENIUS SE & CO KGAA / 1FRE.MI FAQ

What does FRESENIUS SE & CO KGAA do?

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 176,207 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.


What is the stock price of FRESENIUS SE & CO KGAA today?

The current stock price of 1FRE.MI is 46.46 EUR. The price increased by 0.61% in the last trading session.


What is the dividend status of FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (1FRE.MI) has a dividend yield of 2.12%. The yearly dividend amount is currently 0.


What is the ChartMill rating of FRESENIUS SE & CO KGAA stock?

1FRE.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What sector and industry does FRESENIUS SE & CO KGAA belong to?

FRESENIUS SE & CO KGAA (1FRE.MI) operates in the Health Care sector and the Health Care Providers & Services industry.


What is the expected growth for 1FRE stock?

The Revenue of FRESENIUS SE & CO KGAA (1FRE.MI) is expected to grow by 4.78% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the ownership structure of FRESENIUS SE & CO KGAA (1FRE.MI)?

You can find the ownership structure of FRESENIUS SE & CO KGAA (1FRE.MI) on the Ownership tab.


1FRE.MI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to 1FRE.MI.


Chartmill TA Rating
Chartmill Setup Rating

1FRE.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to 1FRE.MI. Both the profitability and the financial health of 1FRE.MI get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1FRE.MI Financial Highlights

Over the last trailing twelve months 1FRE.MI reported a non-GAAP Earnings per Share(EPS) of 3.27. The EPS increased by 1090.91% compared to the year before.


Industry RankSector Rank
PM (TTM) 5.06%
ROA 2.72%
ROE 6.15%
Debt/Equity 0.61
Chartmill High Growth Momentum
EPS Q2Q%6.17%
Sales Q2Q%2.22%
EPS 1Y (TTM)1090.91%
Revenue 1Y (TTM)0.89%

1FRE.MI Forecast & Estimates

23 analysts have analysed 1FRE.MI and the average price target is 51.21 EUR. This implies a price increase of 10.23% is expected in the next year compared to the current price of 46.46.

For the next year, analysts expect an EPS growth of 13.47% and a revenue growth 4.78% for 1FRE.MI


Analysts
Analysts85.22
Price Target51.21 (10.22%)
EPS Next Y13.47%
Revenue Next Year4.78%

1FRE.MI Ownership

Ownership
Inst Owners44.2%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A